Diastolic blood pressure and resting heart rate provide important prognostic information for patients with hemodynamically significant chronic aortic regurgitation (AR), new data show.
Diastolic readings below 70 mm Hg and resting heart rates above 60 beats per minute (bpm) were strongly associated with all-cause mortality in medically managed patients, even after accounting for potential confounders like hypertension, use of various medications, and guideline indications for valve surgery, lead author Li-Tan Yang, MD (Mayo Clinic, Rochester, MN), and colleagues report.
I think the importance of this is that its the first time that diastolic blood pressure and heart rate have been formally evaluated for their association with mortality in aortic regurgitation, and this has in my mind changed some of the clinical paradigms that were believed in our community regarding these two parameters and aortic regurgitation, senior author Hector Michelena, MD (Mayo Clinic), told TCTMD.
The robust link between these measures and mortality is particularly important because it is not a high-tech new technology thats telling us something, it is basic blood pressure taking and heart rate measurement, which is done every day all over the world and has minimal cost or no cost, he added.
The bottom line, Michelena said, is that there is no doubt that diastolic blood pressure and resting heart rate are independently associated with death in patients with significant aortic regurgitation. In fact, they increase, albeit not in an enormous manner, . . . the risk discrimination of death above baseline clinical characteristics and current surgical triggers.
This has in my mind changed some of the clinical paradigms that were believed in our community regarding these two parameters and aortic regurgitation. Hector Michelena
So it appears as though this thing is for real, he continued, and it should in some way or form be included in the armamentarium that we have to evaluate these patients, perhaps as a red flag of increased or heightened death risk that should prompt physicians to do a deeper evaluation or to have a closer monitoring of these patients.
The study was published in the January 7/14, 2020, issue of the Journal of the American College of Cardiology.
Robust Relationships
The investigators note that current guidelines hypothetically caution against the use of medications that could worsen volume overload by causing bradycardia and also hypothetically caution about marked diastolic BP reduction that could impair coronary perfusion. However, these concerns are only conjectural because the clinical significance of diastolic BP and resting heart rate in patients with AR is unknown.
To explore the issue, they retrospectively looked at data spanning from January 2006 to October 2017 on 820 patients with moderate-to-severe AR (mean age 59 years; 92% men). During an average follow-up of 5.5 years, nearly half of patients (49%) underwent valve surgery and 153 (19%) died, including 104 on medical therapy and 49 after valve surgery.
After adjustment for demographics, comorbidities, and guideline-based surgical triggers (including symptoms, LVEF, and LV end-systolic diameter index), the risk of all-cause mortality under medical management was elevated with decreases in baseline diastolic BP (adjusted HR per 10 mm-Hg increase 0.79; 95% CI 0.66-0.94) and increases in baseline resting heart rate (adjusted HR per 10-bpm increase 1.23; 95% CI 1.03-1.45).
Those relationships remained significant in a variety of additional analyses that accounted for the severity of AR, the presence of hypertension, medication use, time-dependent aortic valve surgery, and average diastolic BP and resting heart rate during follow-up (as opposed to a one-time measurement at baseline).
Mortality risk was greater in patients with AR than in their age- and sex-matched counterparts from the general population, and that risk increased as diastolic BP fell (starting at below readings of 70 mm Hg then peaking at 55 mm Hg) and as resting heart rate increased (starting at readings of 60 bpm).
After aortic valve surgery, the relationship between heart rate and mortality remained, but there was no longer an association with diastolic BP, presumably because the pathophysiology underlying the low diastolic BP was corrected by aortic valve surgery, the authors say.
Guiding Patient Evaluation
Yang et al note that the link between increasing heart rate and mortality conflicts with the idea that bradycardia should be avoided in patients with chronic AR.
In our study cohort, 45% of patients presented with resting heart rate 60 bpm, supporting the clinical observation of relative bradycardia in patients with hemodynamically significant AR, they write.
We hypothesize that increased total stroke volume in AR could activate parasympathetic tone, which slows resting heart rate in patients with well-compensated AR. We further suggest that as the severity of AR overwhelms the LV, sympathetic tone activation occurs, resulting in higher resting heart rate, increased myocardial oxygen consumption, and further LV burden, resulting in worse outcomes, they continue. Likewise, we hypothesize that very low diastolic BP could result in coronary hypoperfusion of an already hypertrophied myocardium, leading to worse outcomes.
They add that these hypotheses need to be evaluated in future studies, but, Michelena indicated, clinicians can act on the findings of this new analysis now.
Although no conclusions about causality can be drawn from these data, the associations of diastolic BP and heart rate with mortality are robust and can help guide evaluation of these patients, he said. Because risk is a continuum, strict cutoffs should not be used, Michelena suggested; rather, lower diastolic readings and higher heart ratesespecially when changes in these parameters are seen over timeshould serve as signs that a patient carries a heightened risk of poor outcomes.
These are clearly risk factors and markers of death, which means that something is happening and this disease is progressing, Michelena said. If I am already a specialist, I need to look deep into whats going on to see if this patient needs surgery now, or if Im not a specialist, I need to refer this person to somebody who knows about valves to see if we need to act upon this patient or not regardless of whether the patient [has] symptoms.
In an accompanying editorial, John Chambers, MD (Guys and St Thomas Hospitals, London, England), agrees that low diastolic BP and high resting heart rate can already provide a red flag to alert the clinician to the need for greater vigilance.
This includes taking note of even nonspecific symptoms, considering an exercise test, and rechecking serial echocardiograms for adverse changes, he explains. The authors suggest that they can also be triggers for referring to a heart valve team, but we believe that all patients with severe and even moderate AR should already be seen by cardiologists with specialist valve competencies ideally in a specialist valve clinic.
He concludes by stating that the study is useful in our time of ever-increasing diagnostic sophistication for highlighting the importance of simple physiological markers on the routine clinical examination, which can readily be obtained by all clinicians.
Visit link:
Diastolic BP, Heart Rate Strongly Linked to Death in Chronic Aortic Regurgitation - TCTMD
- Best 30 Cardiology in Secaucus, NJ with Reviews - YP.com - April 12th, 2018 [April 12th, 2018]
- Cardiology | Weill Cornell Medicine - April 14th, 2018 [April 14th, 2018]
- Cardiology Conferences 2018 | Cardiology Meetings 2018 ... - April 26th, 2018 [April 26th, 2018]
- Dr. Anil Goel, MD - Birmingham, MI - Cardiology & Clinical ... - April 26th, 2018 [April 26th, 2018]
- Clinical Physiology (Cardiology) MSc/PGDip | Middlesex ... - May 15th, 2018 [May 15th, 2018]
- Cardiology Conferences 2018 | Upcoming Cardiology ... - May 16th, 2018 [May 16th, 2018]
- Clinical Cardiology Section | Cleveland Clinic - May 27th, 2018 [May 27th, 2018]
- Journal of Clinical and Experimental Cardiology - Open ... - June 6th, 2018 [June 6th, 2018]
- Cardiology Summit 2018 | Cardiology Conferences | Heart ... - June 23rd, 2018 [June 23rd, 2018]
- Cardiology Clinical and Research Faculty Members ... - June 26th, 2018 [June 26th, 2018]
- Cardiology Conferences 2018 | Cardiology Congress 2018 ... - June 26th, 2018 [June 26th, 2018]
- About Us - New Jersey Cardiology Associates - July 8th, 2018 [July 8th, 2018]
- About Us - Ventura Clinical Trials - August 16th, 2018 [August 16th, 2018]
- Clinical Cardiology Made Ridiculously Simple: Michael A ... - August 22nd, 2018 [August 22nd, 2018]
- Clinical Cardiology - American Society of Preventive Cardiology - October 2nd, 2018 [October 2nd, 2018]
- Heart Surgery Hospital in india | Cardiology Treatment ... - October 7th, 2018 [October 7th, 2018]
- Clinical Cardiology - American Society of Preventive ... - December 3rd, 2018 [December 3rd, 2018]
- Guideline Clinical App - American College of Cardiology - December 7th, 2018 [December 7th, 2018]
- Journal of Clinical and Experimental Cardiology- Open ... - December 12th, 2018 [December 12th, 2018]
- Clinical Cardiology - Baptist Health - December 30th, 2018 [December 30th, 2018]
- Cardiology at Cancun: Topics in Clinical Cardiology - February 5th, 2019 [February 5th, 2019]
- Department of Cardiovascular Medicine, KU School of Medicine - March 10th, 2019 [March 10th, 2019]
- Towards Health Equality: Improving the Management of Cardiovascular Diseases in Women - International Atomic Energy Agency - September 21st, 2019 [September 21st, 2019]
- Lifetime Risk of PAD Varies by Race, but All Are Vulnerable to Traditional Risk Factors - TCTMD - September 21st, 2019 [September 21st, 2019]
- DEFINE-HF: Dapagliflozin Improves Function and QoL, but Not Biomarkers, in HFrEF - TCTMD - September 21st, 2019 [September 21st, 2019]
- Combining Nature and Technology, Luye Medical and Cleveland Clinic Join to Build a Future Hospital in Shanghai - Yahoo Finance - September 21st, 2019 [September 21st, 2019]
- Will Renal Denervation for Hypertension Rise Again? - Medscape - September 21st, 2019 [September 21st, 2019]
- Obstructive Sleep Apnea, Sleep Symptoms, and their Association with Cardiovascular Disease - DocWire News - September 21st, 2019 [September 21st, 2019]
- CNE expands pulmonary, sleep services with Brigham & Women's physicians - Warwick Beacon - September 21st, 2019 [September 21st, 2019]
- What I Am Most Looking Forward to at TCT 2019 - TCTMD - September 21st, 2019 [September 21st, 2019]
- Serelaxin Not Linked to CV Mortality Reduction in Patients Hospitalized for Acute HF - The Cardiology Advisor - September 21st, 2019 [September 21st, 2019]
- Sacubitril-Valsartan Not Linked to Lower Hospitalization Risk, CV Death in HFpEF - The Cardiology Advisor - September 21st, 2019 [September 21st, 2019]
- FDA clears multiuse angiography systems from Siemens Healthineers - DOTmed HealthCare Business News - September 21st, 2019 [September 21st, 2019]
- Balloon Pulmonary Angioplasty Effective for Chronic Thromboembolic PH - The Cardiology Advisor - September 21st, 2019 [September 21st, 2019]
- RWJBarnabas Health, St. Luke's University Health launch clinical affiliation - FierceHealthcare - September 21st, 2019 [September 21st, 2019]
- Bilirubin: A Novel Indicator of Infective Endocarditis Adverse Outcomes - The Cardiology Advisor - September 21st, 2019 [September 21st, 2019]
- Major Bleeding Mostly Early, Not Severe With Rivaroxaban Plus Aspirin in COMPASS - TCTMD - September 21st, 2019 [September 21st, 2019]
- Community-based Care Model Reduces CVD Risk - Managed Healthcare Executive - September 21st, 2019 [September 21st, 2019]
- American College of Cardiology Steps Up: Equal Pay, Opportunities for All - TCTMD - September 21st, 2019 [September 21st, 2019]
- FDA Approves Novo Nordisk's Oral Semaglutide, First GLP-1 in Pill Form - AJMC.com Managed Markets Network - September 21st, 2019 [September 21st, 2019]
- A New Drug for HF? DEFINE-HF Bolsters Dapagliflozin Cardio Cred - Medscape - September 21st, 2019 [September 21st, 2019]
- Seeking Synergy: Bringing Cardiology into Your Enterprise Imaging Strategy - Health Imaging - September 21st, 2019 [September 21st, 2019]
- TCT 2019 Day Two: Transcatheter Valves, New and Old - TCTMD - September 30th, 2019 [September 30th, 2019]
- Transcatheter Options Best for Tricuspid Regurgitation in Matched Registry Analysis - TCTMD - September 30th, 2019 [September 30th, 2019]
- Bypass Surgery and Coronary Stenting Yield Comparable 10-Year Survival - Diagnostic and Interventional Cardiology - September 30th, 2019 [September 30th, 2019]
- TAVR Improves Health Status Over Surgery in Low-Risk Patients at 1 Year: PARTNER 3 - TCTMD - September 30th, 2019 [September 30th, 2019]
- Eidos Therapeutics to Present Interim Analysis of the Ongoing Phase 2 Open-Label Extension Study of AG10 in Patients with TTR Amyloid Cardiomyopathy... - September 30th, 2019 [September 30th, 2019]
- Off Script: The New Gatekeepers of Procedural Education - TCTMD - September 30th, 2019 [September 30th, 2019]
- Study Shows Safety and Efficacy of Near Infrared Spectroscopy (NIRS) Imaging to Identify Patients and Plaques at an Increased Risk for MACE - BioSpace - September 30th, 2019 [September 30th, 2019]
- The Heart of the Matter: Cardiovascular Fitness in Horses - United States Eventing Association - September 30th, 2019 [September 30th, 2019]
- Google parent Alphabet hires former FDA head Robert Califf to lead health strategy and policy - FierceHealthcare - September 30th, 2019 [September 30th, 2019]
- Inclisiran Benefits Patients With Familial Hypercholesterolemia and ASCVD - The Cardiology Advisor - September 30th, 2019 [September 30th, 2019]
- AUGUSTUS: Best Benefit With Apixaban, P2Y12 Inhibitor Dual Therapy - Medscape - September 30th, 2019 [September 30th, 2019]
- New TAVR System Safe and Effective for High-Risk Surgical Patients with Severe Aortic Stenosis - Newswise - September 30th, 2019 [September 30th, 2019]
- Dapagliflozin Improves Heart Failure-Related Health Status in HFrEF - The Cardiology Advisor - September 30th, 2019 [September 30th, 2019]
- Remote Ischemic Conditioning Did Not Improve 12 Month Clinical Outcomes After STEMI - The Cardiology Advisor - September 30th, 2019 [September 30th, 2019]
- Insights from the European Society of Cardiology congress | Speaking of Medicine - PLoS Blogs - September 30th, 2019 [September 30th, 2019]
- Smokers Have More Pulmonary Emboli, Leading to Higher Hospital Readmission Rates | - Diagnostic and Interventional Cardiology - October 22nd, 2019 [October 22nd, 2019]
- AZ's Farxiga gets heart failure prevention okay from FDA - PMLiVE - October 22nd, 2019 [October 22nd, 2019]
- Bayer Announces Recipients of the Pulmonary Hypertension Accelerated Bayer (PHAB) Awards at CHEST Annual Meeting 2019 - BioSpace - October 22nd, 2019 [October 22nd, 2019]
- The Epidemic Of The Metabolic Syndrome Among The Palestinians In The G | DMSO - Dove Medical Press - October 22nd, 2019 [October 22nd, 2019]
- Optina Diagnostics and the Montreal Heart Institute Partner to Develop a New Biomarker for Atherosclerosis - PRNewswire - October 22nd, 2019 [October 22nd, 2019]
- Even With Same Diagnosis, Women Get Half the Heart Attack Treatments as Men - AJMC.com Managed Markets Network - October 22nd, 2019 [October 22nd, 2019]
- Eva Dickerman, Andrew Weil - The New York Times - October 22nd, 2019 [October 22nd, 2019]
- EHR vendor Veradigm and partners creating new shared data tools for researchers - Healthcare IT News - October 22nd, 2019 [October 22nd, 2019]
- Evolocumab Well-tolerated as Add-on for Hypercholesterolemia Therapy - DocWire News - October 22nd, 2019 [October 22nd, 2019]
- Deborah Heart and Lung Center announces affiliation with Cleveland Clinic Heart & Vascular Institute - Health Essentials from Cleveland Clinic - October 22nd, 2019 [October 22nd, 2019]
- New Registry to Provide Insight into STEMI Occurrence, Treatment in North India | - Diagnostic and Interventional Cardiology - October 22nd, 2019 [October 22nd, 2019]
- Finding Your Best Fit in Cardiology - TCTMD - October 22nd, 2019 [October 22nd, 2019]
- Cardiology team expands to meet community need - The Union of Grass Valley - October 22nd, 2019 [October 22nd, 2019]
- Deaths After Ablation of Atrial Fibrillation 'Concerning' in Real-World Analysis - TCTMD - November 1st, 2019 [November 1st, 2019]
- Cutler Family gifts $15 million to University Hospitals to transform mens health care - Newswise - November 1st, 2019 [November 1st, 2019]
- Troponin Increases After Elective PCI Tied to Complexity, Extent of CAD - TCTMD - November 1st, 2019 [November 1st, 2019]
- Caregiving and the Soul of Medicine - Medscape - November 1st, 2019 [November 1st, 2019]
- STEMI Mortality Unaffected by Weekend, Weeknight, or Holiday Admission in France - TCTMD - November 1st, 2019 [November 1st, 2019]
- Cardiva Medical publishes positive results from the AMBULATE pivotal study Cardiology2.0 - Cardiology2.0 - November 1st, 2019 [November 1st, 2019]
- Gaps in Access to TAVR and SAVR: 'Something Needs to Be Done' - TCTMD - November 1st, 2019 [November 1st, 2019]
- Cardiva Medical Announces Publication of Data From the AMBULATE Pivotal Study in the Journal of the American College of Cardiology: Clinical... - November 1st, 2019 [November 1st, 2019]
- Raymond James 4 Analyst Favorite Health Care Picks With Huge Upside Potential - 24/7 Wall St. - November 7th, 2019 [November 7th, 2019]
- Global Computed Tomography (CT) Scanners Devices and Equipment Market Report 2020: Major Players are GE Healthcare, Koninklijke Philips, Hitachi,... - November 7th, 2019 [November 7th, 2019]